ABCL
AbCellera Biologics Inc.
+1.19 (+10.20%)12.86USD4.3M成交股數3.9B市值–本益比(近四季)59.6股價營收比-76.3%營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 4.1M-4% | 8.3M+65% | 9.0M+38% | 17.1M+133% | 4.2M-57% | 5.0M-23% | 6.5M-35% | 7.3M-40% | 10.0M | 6.6M | 10.1M | 12.2M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 46.0M | 46.7M | 55.0M | 39.2M | 42.5M | 46.1M | 41.0M | 40.9M | 39.3M | 37.9M | 36.5M | 52.6M |
| 銷售管理費用 | 13.9M | 12.3M | 22.1M | 22.0M | 19.1M | 28.8M | 19.1M | 20.2M | 17.4M | 14.4M | 15.5M | 15.1M |
| 營業利益 | −62.8M+0% | −57.5M-21% | −76.3M-19% | −49.6M-47% | −62.7M+14% | −72.8M+33% | −93.7M+82% | −93.5M+44% | −54.9M | −54.9M | −51.4M | −64.9M |
| 營業利益率 | -1,550.0% | -691.7% | -851.8% | -290.2% | -1,479.6% | -1,441.0% | -1,439.4% | -1,276.2% | -551.5% | -831.8% | -511.0% | -532.1% |
| 稅後淨利 | −55.4M+21% | −43.2M+26% | −57.1M+12% | −34.7M-6% | −45.6M+12% | −34.2M+20% | −51.1M+67% | −36.9M-8% | −40.6M | −28.6M | −30.5M | −40.1M |
| 淨利率 | -1,368.6% | -519.1% | -637.8% | -203.3% | -1,077.2% | -677.6% | -785.4% | -504.3% | -408.0% | -433.6% | -303.6% | -329.0% |
| 稀釋 EPS | -0.18+20% | -0.14+27% | -0.19+12% | -0.12-8% | -0.15+7% | -0.11+10% | -0.17+55% | -0.13-7% | -0.14 | -0.10 | -0.11 | -0.14 |
| 稀釋股數 | 306M | 303M | 299M | 299M | 298M | 294M | 295M | 294M | 293M | 289M | 289M | 288M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 120M | 77.1M | 83.2M | 92.4M | 159M | 156M | 127M | 148M | 124M | 172M | 180M | 193M |
| 應收帳款 | 38.4M | 39.2M | 71.2M | 70.0M | 63.6M | 32.0M | – | – | – | – | – | – |
| 存貨 | 7.6M | 7.9M | – | – | – | 0.00 | – | – | – | – | – | – |
| 總資產 | 1.3B | 1.3B | 1.4B | 1.4B | 1.3B | 1.4B | 1.4B | 1.4B | 1.5B | 1.5B | 1.5B | 1.5B |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 412M | 369M | 392M | 395M | 321M | 304M | 315M | 302M | 333M | 329M | 342M | 289M |
| 股東權益 | 896M | 938M | 964M | 1.0B | 1.0B | 1.1B | 1.1B | 1.1B | 1.1B | 1.2B | 1.2B | 1.2B |
| 負債比 | 31.5% | 28.2% | 28.9% | 28.2% | 23.9% | 22.4% | 22.6% | 21.3% | 22.8% | 21.8% | 22.3% | 19.3% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −33.5M | – | – | −11.6M-72% | – | – | – | −41.7M | – | – | −44.1M |
| 資本支出 | – | 3.8M | – | – | 10.6M | – | – | – | 24.1M | – | – | 15.0M |
| 自由現金流 | – | −37.4M | – | – | −22.2M-66% | – | – | – | −65.8M | – | – | −59.0M |
| 折舊攤銷 | 7.0M | 6.8M | 5.2M | 5.5M | 5.3M | – | 36.9M | 36.5M | 4.8M | 5.7M | 5.6M | 5.5M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -449.2% | – | – | -524.0% | – | – | – | -661.5% | – | – | -484.3% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
地區2025 年度 · 75.1M
| 加拿大 | 64.0M | 85.2% | +144.3% |
|---|---|---|---|
| 美國 | 11.1M | 14.8% | +311.1% |
產品／服務2025 年度 · 75.1M
| License | 46.9M | 62.5% | +4372.8% |
|---|---|---|---|
| Research Fees | 27.2M | 36.2% | +3.5% |
| Milestone Payments | 1.0M | 1.3% | -33.3% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 75.1M | +160.6% | −146M | -194.9% | -0.49 | −174M |
| FY2024 | 28.8M | -24.2% | −163M | -564.8% | -0.55 | −187M |
| FY2023 | 38.0M | -92.2% | −146M | -385.0% | -0.51 | −121M |
| FY2022 | 485M | +29.4% | 159M | 32.7% | 0.50 | 207M |
| FY2021 | 375M | +60.9% | 153M | 40.9% | 0.48 | 186M |
| FY2020 | 233M | +1907.9% | 119M | 51.0% | 0.45 | 13.0M |
| FY2019 | 11.6M | – | −2.2M | -19.0% | -0.01 | −1.3M |